Association between FKBP5 Functional Polymorphisms and Completed Suicide

Neuropsychobiology

Volumn 72, Issue 2, 2015, Pages 126-131

  Fudalej, Sylwia ^a   Kopera, Maciej ^a,d   Wolynczyk Gmaj, Dorota ^b   Fudalej, Marcin ^b   Krajewski, Paweł ^c   Wasilewska, Krystyna ^a   Szymański, Konrad ^b   Chojnicka, Izabela ^a   Podgórska, Anna ^b   Wojnar, Marcin ^a   Płoski, Rafał ^e  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Departments of Forensic Medicine   (Denmark)

^c UNIVERSITY OF WARSAW   (Poland)

^d Institute of Physiology and Pathology of Hearing   (Poland)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Completed suicide; FKBP5 polymorphism; Glucocorticoid receptors; HPA axis

Indexed keywords

FK 506 BINDING PROTEIN; FK506 BINDING PROTEIN 51; UNCLASSIFIED DRUG; TACROLIMUS BINDING PROTEIN 5;

ADULT; ARTICLE; CAUCASIAN; CODOMINANCE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDE; TIME OF DEATH; BIOLOGICAL MODEL; GENETIC PREDISPOSITION; GENETICS; GENOTYPING TECHNIQUE;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SUICIDE; TACROLIMUS BINDING PROTEINS;

EID: 84983138493     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000441659     Document Type: Article

References (39)

1. Mann JJ: Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003; 4: 819-828.
2. Jokinen J, Nordstrom P: HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients. Psychoneuroendocrinology 2008; 33: 1387-1393.
3. Coryell W, Schlesser M: The dexamethasone suppression test and suicide prediction. Am J Psychiatry 2001; 158: 748-753.
4. Mann JJ, Currier D, Stanley B, Oquendo MA, Amsel LV, Ellis SP: Can biological tests assist prediction of suicide in mood disorders? Int J Neuropsychopharmacol 2006; 9: 465-474.
5. Norman W, Brown WA, Miller IW, Keitner GI, Overholser JC: The dexamethasone suppression test and completed suicide. Acta Psychiatr Scand 1990; 81: 120-125.
6. Targum SD, Rosen L, Capodanno AE: The dexamethasone suppression test in suicidal patients with unipolar depression. Am J Psychiatry 1983; 140: 877-879.
7. Black DW, Monahan PO, Winokur G: The relationship between DST results and suicidal behavior. Ann Clin Psychiatry 2002; 14: 83-88.
8. Furczyk K, Schutova B, Michel TM, Thome J, Buttner A: The neurobiology of suicide -a review of post-mortem studies. J Mol Psychiatry 2013; 1: 2.
9. Pariante CM, Miller AH: Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001; 49: 391-404.
10. Binder EB: The role of FKBP5 , a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 2009; 34(suppl 1):S186-S195.
11. Nair SC, Rimerman RA, Toran EJ, Chen S, Prapapanich V, Butts RN, Smith DF: Molecular cloning of human FKBP5 and comparisons of immunophilin interactions with hsp90 and progesterone receptor. Mol Cell Biol 1997; 17: 594-603.
12. Zhang X, Clark AF, Yorio T: Fk506-binding protein 51 regulates nuclear transport of the glucocorticoid receptor ? and glucocorticoid responsiveness. Invest Ophthalmol Vis Sci 2008; 49: 1037-1047.
13. Vermeer H, Hendriks-Stegeman BI, van der Burg B, van Buul-Offers SC, Jansen M: Glucocorticoid-induced increase in lymphocytic FKBP5 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J Clin Endocrinol Metab 2003; 88: 277-284.
14. Magee JA, Chang LW, Stormo GD, Milbrandt J: Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element. Endocrinology 2006; 147: 590-598.
15. Touma C, Gassen NC, Herrmann L, Cheung-Flynn J, Bull DR, Ionescu IA, Heinzmann JM, Knapman A, Siebertz A, Depping AM, Hartmann J, Hausch F, Schmidt MV, Holsboer F, Ising M, Cox MB, Schmidt U, Rein T: Fk506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior. Biol Psychiatry 2011; 70: 928-936.
16. Hubler TR, Scammell JG: Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids. Cell Stress Chaperones 2004; 9: 243-252.
17. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB, Tang Y, Gillespie CF, Heim CM, Nemeroff CB, Schwartz AC, Cubells JF, Ressler KJ: Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. J Am Med Assoc 2008; 299: 1291-1305.
18. Bortsov AV, Smith JE, Diatchenko L, Soward AC, Ulirsch JC, Rossi C, Swor RA, Hauda WE, Peak DA, Jones JS, Holbrook D, Rathlev NK, Foley KA, Lee DC, Collette R, Domeier RM, Hendry PL, McLean SA: Polymorphisms in the glucocorticoid receptor co-chaperone FKBP5 predict persistent musculoskeletal pain after traumatic stress exposure. Pain 2013; 154: 1419-1426.
19. Wilker S, Pfeiffer A, Kolassa S, Elbert T, Lingenfelder B, Ovuga E, Papassotiropoulos A, de Quervain D, Kolassa IT: The role of FKBP5 genotype in moderating long-term effectiveness of exposure-based psychotherapy for posttraumatic stress disorder. Transl Psychiatry 2014; 4:e403.
20. Zimmermann P, Bruckl T, Nocon A, Pfister H, Binder EB, Uhr M, Lieb R, Moffitt TE, Caspi A, Holsboer F, Ising M: Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. Am J Psychiatry 2011; 168: 1107-1116.
21. Willour VL, Chen H, Toolan J, Belmonte P, Cutler DJ, Goes FS, Zandi PP, Lee RS, MacKinnon DF, Mondimore FM, Schweizer B; Bipolar Disorder Phenome Group; NIMH Genetics Initiative Bipolar Disorder Consortium; De-Paulo JR, Gershon ES, McMahon FJ, Potash JB: Family-based association of FKBP5 in bipolar disorder. Mol Psychiatry 2009; 14: 261-268.
22. Binder EB, Salyakina D, Lichtner P, et al: Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 2004; 36: 1319-1325.
23. Roy A, Gorodetsky E, Yuan Q, Goldman D, Enoch MA: Interaction of FKBP5 , a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 2010; 35: 1674-1683.
24. Brent D, Melhem N, Ferrell R, Emslie G, Wagner KD, Ryan N, Vitiello B, Birmaher B, Mayes T, Zelazny J, Onorato M, Devlin B, Clarke G, DeBar L, Keller M: Association of FKBP5 polymorphisms with suicidal events in the Treatment of Resistant Depression in Adolescents (TORDIA) study. Am J Psychiatry 2010; 167: 190-197.
25. Leszczy?ska-Rodziewicz A, Szczepankiewicz A, Naro?na B, Skibi?ska M, Pawlak J, Dmitrzak-W?glarz M, Hauser J: Possible association between haplotypes of the FKBP5 gene and suicidal bipolar disorder, but not with melancholic depression and psychotic features, in the course of bipolar disorder. Neuropsychiatr Dis Treat 2014; 10: 243-248.
26. Perez-Ortiz JM, Garcia-Gutierrez MS, Navarrete F, Giner S, Manzanares J: Gene and protein alterations of FKBP5 and glucocorticoid receptor in the amygdala of suicide victims. Psychoneuroendocrinology 2013; 38: 1251-1258.
27. Supriyanto I, Sasada T, Fukutake M, Asano M, Ueno Y, Nagasaki Y, Shirakawa O, Hishimoto A: Association of FKBP5 gene haplotypes with completed suicide in the Japanese population. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 252-256.
28. WHO International Classification of Diseases (ICD). 2013. http://www.who.int/classifications/icd/en/(accessed January 11, 2015
29. Chojnicka I, Strawa K, Fudalej S, Fudalej M, Pawlak A, Kostrzewa G, Wojnar M, Krajewski P, P?oski R: Analysis of four genes involved in the neurodevelopment shows association of rs4307059 polymorphism in the cadherin 9/10 region with completed suicide. Neuropsychobiology 2012; 66: 134-140.
30. Fudalej S, Ilgen M, Fudalej M, Kostrzewa G, Barry K, Wojnar M, Krajewski P, Blow F, Ploski R: Association between tryptophan hydroxylase 2 gene polymorphism and completed suicide. Suicide Life Threat Behav 2010; 40: 553-560.
31. Ploski R, Wozniak M, Pawlowski R, Monies DM, Branicki W, Kupiec T, Kloosterman A, Dobosz T, Bosch E, Nowak M, Lessig R, Jobling MA, Roewer L, Kayser M: Homogeneity and distinctiveness of polish paternal lineages revealed by Y chromosome microsatellite haplotype analysis. Hum Genet 2002; 110: 592-600.
32. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
33. Hansen SK, Gjesing AP, Rasmussen SK, Glumer C, Urhammer SA, Andersen G, Rose CS, Drivsholm T, Torekov SK, Jensen DP, Ekstrom CT, Borch-Johnsen K, Jorgensen T, McCarthy MI, Hansen T, Pedersen O: Largescale studies of the HphI insulin gene variablenumber-of-tandem-repeats polymorphism in relation to type 2 diabetes mellitus and insulin release. Diabetologia 2004; 47: 1079-1087.
34. Conwell Y, Duberstein PR, Cox C, Herrmann JH, Forbes NT, Caine ED: Relationships of age and axis diagnoses in victims of completed suicide: a psychological autopsy study. Am J Psychiatry 1996; 153: 1001-1008.
35. Szczepankiewicz A, Leszczynska-Rodziewicz A, Pawlak J, Narozna B, Rajewska-Rager A, Wilkosc M, Zaremba D, Maciukiewicz M, Twarowska-Hauser J: FKBP5 polymorphism is associated with major depression but not with bipolar disorder. J Affect Disord 2014; 164: 33-37.
36. Menke A, Klengel T, Rubel J, Bruckl T, Pfister H, Lucae S, Uhr M, Holsboer F, Binder EB: Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression. Genes Brain Behav 2013; 12: 289-296.
37. Simon OR, Swann AC, Powell KE, Potter LB, Kresnow MJ, O'Carroll PW : Characteristics of impulsive suicide attempts and attempters. Suicide Life Threat Behav 2001; 32: 49-59.
38. Sher L: Alcohol consumption and suicide. QJM 2006; 99: 57-61.
39. Holmgren A, Jones AW: Demographics of suicide victims in Sweden in relation to their blood-alcohol concentration and the circumstances and manner of death. Forensic Sci Int 2010; 198: 17-22.